News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
252,387 Results
Type
Article (23421)
Company Profile (109)
Press Release (228856)
Multimedia
Podcasts (46)
Webinars (4)
Section
Business (64124)
Career Advice (310)
Deals (9810)
Drug Delivery (41)
Drug Development (41884)
Employer Resources (23)
FDA (5404)
Job Trends (5337)
News (119861)
Policy (9826)
Tag
2027 Biotech Bay Standard (2)
2027 Genetown Elite (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (1)
Academia (1149)
Academic (1)
Accelerated approval (15)
Adcomms (12)
Allergies (20)
Alliances (19318)
ALS (44)
Alzheimer's disease (341)
Antibody-drug conjugate (ADC) (318)
Approvals (5536)
Artificial intelligence (234)
Autoimmune disease (65)
Automation (7)
Bankruptcy (83)
Best Places to Work (4657)
BIOSECURE Act (4)
Biosimilars (92)
Biotechnology (85)
Bladder cancer (163)
Brain cancer (61)
Breast cancer (672)
Cancer (4988)
Cardiovascular disease (88)
Career advice (300)
Career pathing (5)
CAR-T (241)
CDC (12)
Celiac Disease (1)
Cell therapy (510)
Cervical cancer (38)
Clinical research (35668)
Collaboration (832)
Company closure (4)
Compensation (336)
Complete response letters (24)
COVID-19 (755)
CRISPR (33)
C-suite (304)
Cystic fibrosis (22)
Data (3291)
Decentralized trials (1)
Denatured (12)
Depression (17)
Diabetes (104)
Diagnostics (3540)
Digital health (13)
Diversity (6)
Diversity, equity & inclusion (7)
Drug discovery (107)
Drug pricing (58)
Drug shortages (4)
Duchenne muscular dystrophy (27)
Earnings (23215)
Editorial (16)
Employer branding (4)
Employer resources (23)
Events (42983)
Executive appointments (340)
FDA (6607)
Fibrodysplasia Ossificans Progressiva (3)
Friedreich's ataxia (1)
Frontotemporal dementia (7)
Funding (598)
Gene editing (64)
Generative AI (13)
Gene therapy (185)
GLP-1 (264)
Government (1562)
Grass and pollen (1)
Guidances (115)
Healthcare (7028)
HIV (31)
Huntington's disease (6)
IgA nephropathy (12)
Immunology and inflammation (107)
Immuno-oncology (55)
Indications (59)
Infectious disease (833)
Inflammatory bowel disease (67)
Inflation Reduction Act (11)
Influenza (24)
Intellectual property (101)
Interviews (23)
IPO (5109)
IRA (25)
Job creations (934)
Job search strategy (282)
JPM (26)
Kidney cancer (16)
Labor market (7)
Layoffs (195)
Leadership (3)
Legal (1608)
Liver cancer (98)
Longevity (5)
Lung cancer (682)
Lymphoma (347)
Machine learning (21)
Management (9)
Manufacturing (247)
MASH (54)
Medical device (2352)
Medtech (2360)
Mergers & acquisitions (5046)
Metabolic disorders (307)
Multiple sclerosis (35)
NASH (1)
Neurodegenerative disease (52)
Neuropsychiatric disorders (15)
Neuroscience (559)
NextGen: Class of 2026 (2026)
Non-profit (1811)
Now hiring (13)
Obesity (138)
Opinion (95)
Ovarian cancer (169)
Pain (49)
Pancreatic cancer (233)
Parkinson's disease (49)
Partnered (12)
Patents (195)
Patient recruitment (236)
Peanut (5)
People (20181)
Pharmaceutical (21)
Pharmacy benefit managers (8)
Phase 1 (13139)
Phase 2 (15398)
Phase 3 (10862)
Pipeline (2243)
Policy (107)
Postmarket research (1105)
Preclinical (5382)
Press Release (20)
Prostate cancer (251)
Psychedelics (8)
Radiopharmaceuticals (267)
Rare diseases (257)
Real estate (1620)
Recruiting (6)
Regulatory (8505)
Reports (15)
Research institute (1438)
Resumes & cover letters (17)
Rett syndrome (4)
RNA editing (5)
RSV (26)
Schizophrenia (25)
Series A (89)
Series B (63)
Sickle cell disease (38)
Special edition (5)
Spinal muscular atrophy (36)
Sponsored (11)
Startups (1347)
State (1)
Stomach cancer (20)
Supply chain (22)
Tariffs (23)
The Weekly (34)
Vaccines (377)
Venture capital (32)
Weight loss (80)
Women's health (35)
Worklife (1)
Date
Today (34)
Last 7 days (211)
Last 30 days (778)
Last 365 days (12416)
2026 (1112)
2025 (12575)
2024 (14596)
2023 (16385)
2022 (21161)
2021 (21869)
2020 (19096)
2019 (15748)
2018 (11586)
2017 (12382)
2016 (11656)
2015 (13575)
2014 (10037)
2013 (8119)
2012 (8177)
2011 (8625)
2010 (8049)
Location
Africa (243)
Alabama (18)
Alaska (1)
Arizona (71)
Arkansas (3)
Asia (17530)
Australia (3621)
California (4484)
Canada (1319)
China (696)
Colorado (171)
Connecticut (200)
Delaware (180)
Europe (39903)
Florida (597)
Georgia (105)
Hawaii (1)
Idaho (16)
Illinois (341)
India (32)
Indiana (230)
Iowa (12)
Japan (176)
Kansas (33)
Kentucky (22)
Louisiana (2)
Maine (6)
Maryland (550)
Massachusetts (2981)
Michigan (39)
Minnesota (162)
Mississippi (1)
Missouri (43)
Montana (13)
Nebraska (7)
Nevada (22)
New Hampshire (37)
New Jersey (1528)
New Mexico (11)
New York (1375)
North Carolina (377)
North Dakota (2)
Northern California (2335)
Ohio (102)
Oklahoma (1)
Oregon (10)
Pennsylvania (725)
Puerto Rico (6)
Rhode Island (11)
South America (262)
South Carolina (11)
Southern California (1706)
Tennessee (40)
Texas (991)
United States (15657)
Utah (92)
Virginia (64)
Washington D.C. (22)
Washington State (487)
West Virginia (2)
Wisconsin (71)
Wyoming (1)
252,387 Results for "peter maccallum cancer centre".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
HaemaLogiX and Peter MacCallum Cancer Centre Announce Myeloma CAR-T Phase I Clinical Trial Agreement
HaemaLogiX and Peter MacCallum Cancer Centre have entered a collaboration agreement to develop and conduct the first Phase I human trial of HaemaLogiX’s CAR-T cell therapy in patients with kappa-type myeloma.
July 25, 2023
·
3 min read
Press Releases
Peter Gilgan donates $50 million - the largest single gift to Support Early Cancer Detection in North America
November 27, 2025
·
4 min read
Peter MacCallum Cancer Centre and Cartherics Announce Collaboration to Develop Autologous CAR-T Cell Therapy for Ovarian Cancer
Peter MacCallum Cancer Centre (“Peter Mac”) and Cartherics Pty Ltd (“Cartherics”) announced today they have entered into a Collaborative Development Program Agreement (CDPA) to develop Cartherics’ proprietary autologous CAR-T cell therapy (CTH-004) for the treatment of ovarian cancer.
February 27, 2023
·
5 min read
Press Releases
Taiho Oncology Appoints Peter Melnyk as President & Chief Executive Officer
January 29, 2026
·
2 min read
Press Releases
Peter Melnyk Joins Taiho Oncology as President & Chief Operating Officer
January 21, 2026
·
2 min read
Press Releases
Ipsen nominates Peter Guenter to its Board of Directors
January 29, 2026
·
6 min read
Peter MacCallum Cancer Centre and Cartherics Announce Collaboration to Develop Autologous CAR-T Cell Therapy for Cutaneous T-Cell Lymphoma
The Peter MacCallum Cancer Centre (“Peter Mac”) and Cartherics Pty Ltd (“Cartherics”) announced today they have entered into a Collaborative Development Program Agreement (CDPA) to develop Cartherics’ proprietary autologous CAR-T cell therapy (CTH-001) for the treatment of cutaneous T-cell lymphoma (CTCL).
November 8, 2022
·
4 min read
Press Releases
Tango Therapeutics Announces CEO Transition: Barbara Weber to Retire, Malte Peters Appointed Successor
January 9, 2026
·
11 min read
Press Releases
Propanc Biopharma Unveils PRP: A Game-Changing Proenzyme Therapy Poised to Challenge Standard Cancer Treatments in the $3+ Billion Pancreatic Cancer Market
February 5, 2026
·
5 min read
Press Releases
Bantam Pharmaceutical Announces First Patient Treated in BTM-3566 Phase 1 Clinical Trial at Princess Margaret Cancer Centre in Toronto
December 10, 2025
·
3 min read
1 of 25,239
Next
